JOURNAL OF NEUROLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2024-07-07 ms8000000484417572 来自浙江省

投稿命中率:25.0
偏重的研究方向：神经系统肿瘤
经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗

21 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2024-07-22 ms7000000934383955

已经submission to journal 6天了，没有动静，还不如给我拒了

8 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2024-07-07 ms8000000484417572 来自浙江省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：神经系统肿瘤;神经外科
经验分享：已投。

26 0

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2024-05-06 roric5 来自陕西省

审稿速度:1.0 | 投稿命中率:25.0
经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了

33 0

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2014-09-29 bingojean

审稿速度:1.0 | 投稿命中率:25.0
经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。
而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。

410 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2021-04-01 ms9000001571807559

请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了

101 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2022-11-02 隐形的翅膀

审稿速度:1.0 | 投稿命中率:25.0
经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊

127 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2024-01-08 阿杰11 来自黑龙江省

求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静

58 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2023-06-28 CottonBlue 来自湖北省

审稿速度:1.0
经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊

79 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2213747, encodeId=7c9b2213e47ba, content=投稿命中率:25.0 偏重的研究方向：神经系统肿瘤 经验分享：s u b m i t t e d t o j o u r n a l两天了，估计编辑正在处理吧，有一样的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:41:39 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2216243, encodeId=b3c422162430d, content=已经submission to journal 6天了，没有动静，还不如给我拒了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e1c9293507, createdName=ms7000000934383955, createdTime=Mon Jul 22 12:08:02 CST 2024, time=2024-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2213739, encodeId=fa7c2213e392c, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：神经系统肿瘤;神经外科 经验分享：已投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d9273618, createdName=ms8000000484417572, createdTime=Sun Jul 07 16:18:42 CST 2024, time=2024-07-07, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2201943, encodeId=3ead2201943b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：拒稿了。期刊拒稿信例有提90%的拒稿率。Due to the large number of manuscripts the Journal receives and the requisite high rejection rate (about 90%)。不过编辑效率挺高，不合适很快就拒稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=roric5, createdTime=Mon May 06 09:05:32 CST 2024, time=2024-05-06, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=506440, encodeId=7774506440f3, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑提供的拒稿率为90％，拒稿没有意见，编辑不要就是不要。你没治。 而且所属Springer的投稿要求很不清楚，需要反复与投稿系统的助理沟通，大家有需要的可以问我怎么投，过来人了。。。在这里攒人品，希望马上有文章。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=410, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dab188647, createdName=bingojean, createdTime=Mon Sep 29 22:29:00 CST 2014, time=2014-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=953200, encodeId=ffa9953200a5, content=请问各位大神，这个杂志接受基础性的研究还是临床类型的研究？谢谢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=ms9000001571807559, createdTime=Thu Apr 01 23:48:41 CST 2021, time=2021-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098115, encodeId=a39120981156d, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：神经性肌病临床实验文章投稿。2022-9-6号投稿，2022-10-3一审意见回来，3个审稿人，大大小小接近80多个问题，有些问题非常雕专，日夜兼程的改了1个月，2022-11-1上午11:40返修回去，2022-11-1下午 14：24显示accepted，竟然只用来3个小时，返修后编辑就直接审稿拍板接收了，这速度简直惊人的让人五体投地。这个杂志是老牌期刊，拒稿率90%以上，之前被秒拒过，这次有幸被接受，太激动，新的IF=6.67，逐年上升，搞不好，明年可以冲到8分，很看好这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6c575239091, createdName=隐形的翅膀, createdTime=Wed Nov 02 21:12:43 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2179896, encodeId=c30621e9896ed, content=求问，为什么 s u b m i t t e d t o j o u r n a l好几天了，还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7ec5634457, createdName=阿杰11, createdTime=Mon Jan 08 08:17:16 CST 2024, time=2024-01-08, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2145172, encodeId=abd721451e248, content=审稿速度:1.0 经验分享：编辑非常高效，按照编辑给的意见修改，大修后直接接受，没有多余的废话，整体审稿时间一个月，非常感谢这个期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210430/93d5a69806694178992860f4bc5381db/691fec10e73e496d80c33ae33d2445ea.jpg, createdBy=68915449010, createdName=CottonBlue, createdTime=Wed Jun 28 09:37:50 CST 2023, time=2023-06-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2171253, encodeId=a1f921e12530a, content=请问纯临床接受吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed108843813, createdName=ms7000001113449944, createdTime=Mon Nov 27 12:21:28 CST 2023, time=2023-11-27, status=1, ipAttribution=海南省)]

2023-11-27 ms7000001113449944 来自海南省

请问纯临床接受吗

44 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务